Neumora Therapeutics (NMRA) Institutional Ownership $2.05 -0.12 (-5.53%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Neumora Therapeutics (NASDAQ:NMRA)CurrentInstitutional OwnershipPercentage47.65%Number ofInstitutional Buyers(last 12 months)35TotalInstitutional Inflows(last 12 months)$85.98MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$14.61M Get NMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NMRA Institutional Buying and Selling by Quarter Neumora Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/17/2025 SG Americas Securities LLC14,119$150K0.0%-34.6%0.009% 12/26/2024JPMorgan Chase & Co.64,421$851K0.0%+2.6%0.040% 11/27/2024Franklin Resources Inc.75,702$1M0.0%-13.9%0.047% 11/19/2024Barclays PLC129,210$1.71M0.0%+352.9%0.080% 11/16/2024Geode Capital Management LLC1,979,847$26.16M0.0%+54.0%1.225% 11/15/2024Barclays PLC129,210$1.71M0.0%+352.9%0.080% 11/15/2024Wexford Capital LP217,879$2.88M0.7%+90.1%0.135% 11/15/2024State Street Corp1,790,707$23.66M0.0%+65.3%1.108% 11/15/2024Quarry LP5,000$66K0.0%-50.0%0.003% 11/15/2024Point72 Asset Management L.P.83,077$1.10M0.0%N/A0.051% Get the Latest News and Ratings for NMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024FMR LLC7,749,156$102.37M0.0%-10.1%4.842% 11/13/2024The Manufacturers Life Insurance Company109,802$1.45M0.0%-1.8%0.069% 11/12/2024Cerity Partners LLC242,900$3.21M0.0%N/A0.152% 11/12/2024Charles Schwab Investment Management Inc.698,255$9.22M0.0%+139.7%0.436% 11/9/2024Intech Investment Management LLC13,275$175K0.0%N/A0.008% 10/30/2024Auour Investments LLC250,000$3.30M1.2%N/A0.156% 10/23/2024 Ballentine Partners LLC13,441$178K0.0%N/A0.008% 10/9/2024 Clarius Group LLC16,992$224K0.0%N/A0.011% 10/5/2024Handelsbanken Fonder AB26,600$351K0.0%+35.0%0.017% 10/3/2024 SG Americas Securities LLC21,581$285K0.0%-62.5%0.014% 8/27/2024Logos Global Management LP300,000$2.95M0.2%-21.5%0.188% 8/16/2024Quarry LP10,000$98K0.0%N/A0.006% 8/15/2024The Manufacturers Life Insurance Company111,828$1.10M0.0%+79.5%0.070% 8/14/2024Marshall Wace LLP134,545$1.32M0.0%N/A0.084% 8/14/2024Logos Global Management LP300,000$2.95M0.2%-21.5%0.188% 8/13/2024Callan Capital LLC661,194$6.50M0.5%+222.6%0.414% 8/12/2024SkyOak Wealth LLC15,000$147K0.0%N/A0.009% 8/12/2024Amalgamated Bank2,910$29K0.0%+472.8%0.002% 8/3/2024TD Asset Management Inc144,994$1.43M0.0%+31.6%0.091% 8/1/2024Rhumbline Advisers103,258$1.02M0.0%+488.3%0.065% 7/29/2024Principal Financial Group Inc.16,878$166K0.0%N/A0.011% 7/26/2024Bank of New York Mellon Corp235,593$2.32M0.0%+474.1%0.148% 7/12/2024 SG Americas Securities LLC57,607$566K0.0%N/A0.036% 5/17/2024Artal Group S.A.2,924,052$40.21M1.0%+14.5%1.833% 5/16/2024Kennedy Capital Management LLC136,828$1.88M0.0%N/A0.086% 5/15/2024Baker BROS. Advisors LP633,851$8.72M0.1%N/A0.397% 5/15/2024Price T Rowe Associates Inc. MD752,924$10.35M0.0%N/A0.472% 5/14/2024Nan Fung Group Holdings Ltd63,315$871K0.8%N/A0.040% 5/10/2024Vanguard Group Inc.334,330$4.60M0.0%-12.2%0.210% 5/3/2024Callan Capital LLC204,987$2.82M0.2%N/A0.129% Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately.5/1/2024Auour Investments LLC105,087$1.45M0.5%N/A0.066% 4/23/2024Addis & Hill Inc314,821$4.19M3.6%N/A0.198% 4/22/2024Windmill Hill Asset Management Ltd26,121$359K0.1%N/A0.016% 2/14/2024Avidity Partners Management LP1,990,632$33.94M1.2%+10.6%1.304% 2/13/2024Tower Research Capital LLC TRC2,558$44K0.0%N/A0.002% 2/6/2024Amalgamated Bank1,709$29K0.0%N/A0.001% 2/1/2024New York State Common Retirement Fund6,900$118K0.0%N/A0.005% 1/30/2024Strs Ohio3,200$54K0.0%N/A0.002% 1/12/2024 SG Americas Securities LLC6,308$108K0.0%N/A0.004% 12/6/2023Citigroup Inc.14,416$203K0.0%N/A0.009% 11/15/2023Laurion Capital Management LP21,557$304K0.0%N/A0.014% 11/14/2023Soros Fund Management LLC10,000$141K0.0%N/A0.007% 11/14/2023Avidity Partners Management LP1,800,000$25.40M1.0%N/A1.179% 11/13/2023FMR LLC5,624,353$79.36M0.0%N/A3.683% 11/9/2023Johnson & Johnson912,128$12.87M4.7%N/A0.597% 10/23/2023 WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST3,309,124$46.69M0.6%N/A2.178% (Data available from 1/1/2016 forward) NMRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NMRA shares? During the previous two years, 44 institutional investors and hedge funds held shares of Neumora Therapeutics. The most heavily invested institutionals were FMR LLC ($102.37M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($46.69M), Artal Group S.A. ($40.21M), Avidity Partners Management LP ($33.94M), Geode Capital Management LLC ($26.16M), State Street Corp ($23.66M), and Johnson & Johnson ($12.87M).Learn more on NMRA's institutional investors. What percentage of Neumora Therapeutics stock is owned by institutional investors? 47.65% of Neumora Therapeutics stock is owned by institutional investors. Learn more on NMRA's institutional investor holdings. Which institutional investors have been buying Neumora Therapeutics stock? Of the 41 institutional investors that purchased Neumora Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.62M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($3.31M), Avidity Partners Management LP ($1.99M), Johnson & Johnson ($912.13K), Price T Rowe Associates Inc. MD ($752.92K), State Street Corp ($707.41K), and Geode Capital Management LLC ($694.39K). How much institutional buying is happening at Neumora Therapeutics? Institutional investors have bought a total of 18,310,940 shares in the last 24 months. This purchase volume represents approximately $251.06M in transactions. Which Neumora Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Neumora Therapeutics stock in the last 24 months: FMR LLC ($873.31K), Logos Global Management LP ($164.69K), Vanguard Group Inc. ($46.62K), SG Americas Securities LLC ($43.49K), Franklin Resources Inc. ($12.24K), Quarry LP ($5K), and The Manufacturers Life Insurance Company ($2.03K). How much institutional selling is happening at Neumora Therapeutics? Institutional investors have sold a total of 1,147,381 shares in the last 24 months. This volume of shares sold represents approximately $14.61M in transactions. Related Companies Dyne Therapeutics Institutional Ownership Immunocore Institutional Ownership Evotec Institutional Ownership Vir Biotechnology Institutional Ownership Structure Therapeutics Institutional Ownership Travere Therapeutics Institutional Ownership Schrödinger Institutional Ownership Xencor Institutional Ownership Nurix Therapeutics Institutional Ownership Ardelyx Institutional Ownership This page (NASDAQ:NMRA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
